4//SEC Filing
Baldasare Bryan T 4
Accession 0001127602-21-004269
CIK 0000794172other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 10:21 AM ET
Size
8.8 KB
Accession
0001127602-21-004269
Insider Transaction Report
Form 4
Baldasare Bryan T
Chief Accounting Officer
Transactions
- Sale
Common Stock
2021-02-05$26.61/sh−14,250$379,126→ 58,632 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-02-05−11,250→ 3,750 totalExercise: $19.56Exp: 2026-03-24→ Common Stock (11,250 underlying) - Exercise/Conversion
Common Stock
2021-02-05$19.56/sh+11,250$220,050→ 72,882 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
- [F2]Prices range from $25.00 per share to $29.00 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
- [F3]The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
- [F4]These non-qualified options were awarded under the 2012 Stock Incentive Plan and vested in four equal installments from the date of grant and were fully vested on March 24, 2020.
Documents
Issuer
MERIDIAN BIOSCIENCE INC
CIK 0000794172
Entity typeother
Related Parties
1- filerCIK 0001761920
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 10:21 AM ET
- Size
- 8.8 KB